As opposed to other specific lymphoma subtypes, the expression and the role of ICP molecules, such as programmed death ligand-1 (PD-L1) in MCL remains controversial, as the early trials of immunotherapy were not conclusive. The gene discussed is CD274; the disease is mantle cell lymphoma.